The Government will invest an additional $6 billion in Medicare from $25 billion in 2018–19 to $31 billion in 2022–23. The government will respond to recommendations from the independent, clinician-led Medicare Benefits Schedule (MBS) Review Taskforce.
The MBS Review Taskforce is advising the Government about how to modernise the MBS, align it with contemporary clinical practice, and improve patient outcomes.
Guaranteeing Medicare – Medicare Benefits Schedule Review – response to Taskforce recommendations
About this resource
Publication date:
Publication type:
Fact sheet
Audience:
General public
Language:
English
Part of a collection: